Dr. Jodele is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3333 Burnet Ave
MLC 11027
Cincinnati, OH 45229Phone+1 513-636-5917- Is this information wrong?
Summary
- I am a Research Professor in the Division of Bone Marrow Transplantation and Immune Deficiency at Cincinnati Children's Hospital Medical Center (CCHMC). The overall focus of my research is to reduce organ toxicity in children and young adults undergoing a hematopoietic stem cell transplant (HCT). My primary research interest is transplant-associated thrombotic microangiopathy (TMA). TMA is systemic vascular endothelial injury that occurs during HCT. TMA can result in multi-organ injury and effects overall outcomes. My research effort is targeted towards understanding the pathogenesis of organ injury after HCT, developing screening and early diagnostic tools and investigating novel therapeutic interventions. I have national and international collaborations with colleagues in Nephrology, Cardiology, Critical Care, Genetics, Pharmacology, Bioinformatics. Our collaborative research on TMA has resulted in significant changes to the clinical care of transplant patients, publications, presentations at national and international scientific meetings, working committees and NIH funded research projects.
Education & Training
Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 2001 - 2004
SUNY Downstate Health Sciences UniversityResidency, Pediatrics, 1998 - 2001
Vilnius University Faculty of MedicineClass of 1994
Certifications & Licensure
CA State Medical License 2001 - 2025
OH State Medical License 2004 - 2024- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients Start of enrollment: 2018 Aug 03
- Ultra-high Dose Vitamin D for HSCT Start of enrollment: 2018 Dec 10
Publications & Presentations
PubMed
- Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy.Michelle L Schoettler, Leslie Lehmann, Pei-Chi Kao, Nan Chen, Sonata Jodele, Satheesh Chonat, Kirsten M Williams, Wendy B London, Christine Duncan, Christopher Dandoy> ;Blood Advances. 2024 Mar 12
- 2 citationsA prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation-associated TMA.Sonata Jodele, Christopher E Dandoy, Paibel Aguayo-Hiraldo, Adam Lane, Ashley Teusink-Cross, Anthony Sabulski, Kana Mizuno, Stella M Davies, Benjamin L Laskin, Jason F...> ;Blood. 2024 Mar 21
- 2 citationsIntestinal permeability in patients undergoing stem cell transplantation correlates with systemic acute phase responses and dysbiosis.Koo, J., YunZu Michele Wang, Sheyar Abdullah, Nathan Luebbering, Lucille Langenberg, Alexandra Duell, Kelly Lake, Adam Lane, Brian Hils, Ormarie Vazquez Silva, Monica ...> ;Blood Advances. 2023 Sep 12
- Join now to see all
Hospital Affiliations
Cincinnati Children's Hospital Medical CenterCincinnati, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
